A Study of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU).

NCT03137069 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

134

Enrollment

INDUSTRY

Sponsor class

Conditions

Urticaria

Interventions

DRUG: GDC-0853
DRUG: Placebo

Sponsor

Genentech, Inc.